Indanide 200 Inhaler CFC Free is a combination inhalation aerosol containing Indacaterol 75 mcg and Budesonide 200 mcg per actuation, formulated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma. Indacaterol is a long-acting β2-adrenergic receptor agonist (LABA) that provides sustained bronchodilation by relaxing airway smooth muscle, thereby improving airflow and reducing symptoms of bronchospasm. Budesonide is a corticosteroid with potent anti-inflammatory properties that reduces airway inflammation, decreases mucus production, and prevents exacerbations. The CFC-free formulation ensures environmental safety without compromising drug delivery efficacy. Indanide 200 Inhaler is indicated for patients requiring both bronchodilation and anti-inflammatory therapy to achieve optimal control of respiratory symptoms and improve lung function. The recommended dosage involves inhalation of one actuation twice daily, with proper inhaler technique to maximize drug deposition in the lower respiratory tract. Adverse effects may include headache, throat irritation, cough, and potential systemic corticosteroid-related effects with prolonged use. Caution is advised in patients with cardiovascular disorders, and the medication should be used under medical supervision. Indanide 200 Inhaler CFC Free offers a convenient, effective option for long-term management of obstructive airway diseases.